# Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban

> **NCT03136510** · NA · TERMINATED · sponsor: **Hopital Lariboisière** · enrollment: 12 (actual)

## Conditions studied

- Coagulation Disorder
- Non Valvular Atrial Fibrillation

## Interventions

- **DRUG:** Apixaban 5 mg

## Key facts

- **NCT ID:** NCT03136510
- **Lead sponsor:** Hopital Lariboisière
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** not enough patients
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136510, "Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03136510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*